Dysregulation of chemo-cytokine production in schizophrenic patients versus healthy controls
Open Access
- 25 January 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Neuroscience
- Vol. 12 (1), 13
- https://doi.org/10.1186/1471-2202-12-13
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Cytokine Changes and Tryptophan Metabolites in Medication-Naïve and Medication-Free Schizophrenic PatientsNeuropsychobiology, 2009
- Chemokines in and out of the central nervous system: much more than chemotaxis and inflammationJournal of Leukocyte Biology, 2008
- From inflammation to sickness and depression: when the immune system subjugates the brainNature Reviews Neuroscience, 2008
- Inflammation-related genes up-regulated in schizophrenia brainsBMC Psychiatry, 2007
- Interferon β-1b modulates MCP-1 expression and production in relapsing–remitting multiple sclerosisJournal of Neuroimmunology, 2002
- Neopterin and Macrophage Inflammatory Protein-1α in the Cerebrospinal Fluid of Schizophrenic Patients: No Evidence of Intrathecal InflammationNeuropsychobiology, 2002
- The Th2-hypothesis of schizophrenia: a strategy to identify a subgroup of schizophrenia caused by immune mechanismsMedical Hypotheses, 2001
- Serum IL‐1β, sIL‐2R, IL‐6, IL‐8 and TNF‐α in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatmentMediators of Inflammation, 2000
- Elevated circulating levels of IL-6 in schizophreniaSchizophrenia Research, 1996
- Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTESNature, 1990